stockrowIncannex Healthcare Inc. (IXHL) vs Talphera, Inc. (TLPH)
- Incannex Healthcare Inc. IXHL 2.23 −1.76%
- Talphera, Inc. TLPH 1.06 +4.95%
Incannex Healthcare Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $52.4M against $28.5M — 1.8× the size. Across the 12 metrics below, Incannex Healthcare Inc. leads on 8 and Talphera, Inc. on 4.
Valuation
| Metric | IXHL | TLPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | 16.88 | 180.84 | 2.08 |
| P/B | 0.39 | 5.35 | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | 1.65 | n/m | 12.22 |
| EV/Sales | (24.08) | 155.68 | 2.87 |
| Earnings yield | (75.75%) | (26.47%) | (15.94%) |
| Free cash flow yield | (48.87%) | (12.52%) | 0.00% |
Profitability
| Metric | IXHL | TLPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | (0.10%) | 100.00% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (47.80%) | (143.36%) | (0.80%) |
| Return on assets | (41.32%) | (69.60%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack